Amalgamated Bank’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
SF
Amalgamated Bank's AVXL Position: Q1 2026 in Review
Amalgamated Bank sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 2,626 shares — an estimated $9K sold.
Amalgamated Bank first reported a position in AVXL in Q2 2021 and held it in 19 quarters. The position peaked at $268K in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.
- Amalgamated Bank reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 2,626 Anavex Life Sciences shares in Q1 2026, an estimated $9K.
- Amalgamated Bank first reported a position in Anavex Life Sciences in Q2 2021 and held it in 19 quarters.
- Amalgamated Bank's Anavex Life Sciences position peaked at $268K in Q2 2021.
- 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.